首页 › 基金 › Redmile Group, LLC › STOK
Redmile Group, LLC 对 STOK 的持仓历史
STOKE THERAPEUTICS INC · 医疗保健
Redmile Group, LLC 在 Q2 2026 的 13F 申报中披露持有 STOK(STOKE THERAPEUTICS INC)3,945,920 股,市值约 US$129.1M,约占其申报组合的 8.67%,在其申报持仓中市值排名第 3 位。 Redmile Group, LLC 最近 12 个申报季度中有 12 个季度披露了 STOK 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Redmile Group, LLC 对 STOK 的持仓演变
Redmile Group, LLC 于 Q3 2023 首次披露 STOK 持仓:3,872,696 股(约 US$15.3M)。 该持仓在 Q1 2026 达到峰值 4,164,120 股,市值约 US$135.6M。 在 12 次申报中,Redmile Group, LLC 2 次增持、8 次减持、1 次保持不变。 最近一期申报(Q2 2026)显示持股 3,945,920 股、市值约 US$129.1M,环比减持 -218,200 股。。 持仓曾出现大幅变动:Q4 2023 减持约 32% (随后一个季度股价上涨 157%)、Q1 2024 增持约 93% (随后一个季度股价基本持平)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 3.87M | $15.26M | 新进 |
| Q4 2023 | 2.63M | $13.81M | 减持 |
| Q1 2024 | 5.07M | $68.49M | 增持 |
| Q2 2024 | 4.72M | $63.78M | 减持 |
| Q3 2024 | 4.71M | $57.93M | 持有 |
| Q4 2024 | 4.59M | $50.67M | 减持 |
| Q1 2025 | 4.49M | $29.83M | 减持 |
| Q2 2025 | 4.38M | $49.67M | 减持 |
| Q3 2025 | 4.18M | $98.13M | 减持 |
| Q4 2025 | 4.03M | $128.04M | 减持 |
| Q1 2026 | 4.16M | $135.58M | 增持 |
| Q2 2026 | 3.95M | $129.11M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 STOK 与 13F 数据
STOK(STOKE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 52 只申报持有 STOK,申报仓位最大的包括:RTW INVESTMENTS, LP (US$184.0M), Lynx1 Capital Management LP (US$132.1M), BAKER BROS. ADVISORS LP (US$109.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 STOK 的基金
- RTW INVESTMENTS, LP 5.62M 股 · $184.00M · Q2 2026
- Lynx1 Capital Management LP 4.04M 股 · $132.14M · Q2 2026
- BAKER BROS. ADVISORS LP 3.34M 股 · $109.18M · Q2 2026
- TORONTO DOMINION BANK 3.17M 股 · $103.83M · Q2 2026
- BVF INC/IL 2.55M 股 · $83.36M · Q2 2026
- Siren, L.L.C. 2.00M 股 · $65.29M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.82M 股 · $59.66M · Q2 2026
- EcoR1 Capital, LLC 735.00K 股 · $24.05M · Q2 2026
- MPM BioImpact LLC 723.31K 股 · $23.67M · Q2 2026
- Opaleye Management Inc. 700.00K 股 · $22.90M · Q2 2026
- Troluce Capital Advisors LLC 496.42K 股 · $16.24M · Q2 2026
- Granahan Investment Management, LLC 461.61K 股 · $15.10M · Q2 2026
更多关于 Redmile Group, LLC
常见问题
How long has Redmile Group, LLC held STOK?
Redmile Group, LLC has disclosed STOK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Redmile Group, LLC's current position in STOK?
As of Q2 2026, Redmile Group, LLC holds 3.95M shares of STOK (STOKE THERAPEUTICS INC), valued at $129.11M, representing 8.67% of its reported portfolio and ranking #3.
Has Redmile Group, LLC been buying or selling STOK?
In the latest 13F filing (Q2 2026), Redmile Group, LLC reduced its position in STOK. The position peaked in Q1 2026 at 4.16M shares.
Which other funds hold STOK?
Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, BAKER BROS. ADVISORS LP, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.